Search results
381 Results for 'Synthetic Biology'
- Technologies (38)
- Collaborations (1)
- Team (0)
- News (264)
- Pages (0)
- Multimedia (78)
- Publications (0)
- Jobs (0)
- Events (0)
Technologies 38
-
PFASense: Fast, In-Field Testing for Forever Chemicals
PFASense is a next-generation diagnostic tool designed to detect toxic ‘forever chemicals’ directly at the source. By combining engineered protein sensors with a portable electrochemical device, it enables real-time, low-cost monitoring of water supplies—providing actionable insights to protect health and guide remediation. -
GeneSkin: A Novel mRNA Therapy for Skin and Hair Rejuvenation
GeneSkin is developing novel mRNA therapies to rejuvenate skin and hair by targeting basal stem cells. Using advanced microneedle delivery, our non-invasive treatments aim to reduce scarring, reverse aging, and promote hair growth, offering transformative solutions for millions worldwide. -
GC Therapeutics: Changing the Future of Cell Therapies
GC Therapeutics (GCTx) is applying their stem cell-engineering TFome platform to overcome barriers in the development and manufacturing of cell therapies to improve patient access across a broad range of disease areas. -
Instrument-Free Molecular Diagnostics
A synthetic biology-based molecular diagnostics platform that enables the creation of low-cost, highly accurate tests for non-clinical settings. -
AminoX: Making Better Protein Drugs, Quicker and Cheaper
AminoX enables protein drugs to only become active in the tumor microenvironment and not elsewhere in the body to avoid immune-related adverse effects in the body. By designing and building non-standard amino acids into strategic positions of protein drugs, AminoX provides tumor-specific, and longer-lasting target inhibition. -
Engineered Live Biotherapeutic Product (eLBP) to Protect the Microbiome from Antibiotics
eLBP is a safe and cost-effective therapeutic for patients treated with beta-lactam antibiotics that safeguards against the loss of health-essential microbes while preventing the development and spread of antibiotic resistance.
Collaborations 1
Brigham-Wyss DxANews 264
Multimedia 78
-
Video/AnimationGeorge Church on Widespread Genomic Sequencing, Xenotransplantation, and Shepherding ChangeIn this interview, GenomeWeb speaks to Core Faculty member George Church, Ph.D., who is also a professor at Harvard Medical School and the Harvard-MIT Program in Health Sciences and Technology. A thinker, inventor, and collaborator extraordinaire, Church’s technologies and personality catalyzed the Human Genome Project, the Personal Genome Project, and more than 50 biotech startups,... -
Video/AnimationEngineering Living Materials with Peter Q. NguyenIn this episode of the CoreSpin Podcast Interview Series, host Misha Bagirov sits down with Wyss Senior Scientist Peter Q. Nguyen, Ph.D., to explore how synthetic biology can turn biofilms into useful materials, embed cell-free systems into wearables (like COVID-sensing masks), and program probiotics as future therapeutics. We also talked about the philosophy behind bioengineering,... -
Video/AnimationGeorge Church: Embracing Outliers in Science and in LifeGeorge Church, Ph.D., is a Core Faculty member at the Wyss Institute and a genetics professor at Harvard Medical School. He is a pioneer in synthetic biology and personalized genomics. In 2017, Time magazine named him as one of the 100 most influential people in the world. In addition to being a scientist, Church is...
-
Video/Animation20-ish Questions with Pamela Silver20-ish Questions shows a different side of Wyss Institute faculty, touching on aspects of their personal life, hobbies, interests, as well as their research. This round follows Pamela Silver, a Founding Core Faculty member of the Wyss Institute as well as the Elliot T. and Onie H. Adams Professor of Biochemistry and Systems Biology at... -
Video/AnimationThe End of Aging—And Extinction | George Church, Ph.D. on Longevity, Dire Wolves, and Woolly MammothsWhat if aging was optional—and extinction reversible? In this episode of Ignition Sequence, Wyss Core Faculty member and geneticist and biotech pioneer, George Church, Ph.D., joins host Dylan Bohbot to explore the frontiers of gene therapy, de-extinction, and the future of human health. A founding scientist behind the Human Genome Project, and co-founder of Colossal... -
Video/AnimationFinding a Balance In Bipolar Disorder Through Drug Prediction and Organoid-Based Drug ScreeningCircaVent is a high-throughput drug screening platform that combines predictive algorithms, preclinical models, and human brain organoids to efficiently identify and test drugs that could treat the underlying causes of bipolar disorder. CircaVent is initially focused on addressing the circadian rhythm disruptions that are a common hallmark of BD, and could dramatically speed up the...